US Broker Ratings

Establishment Labs Holdings Inc (ESTA) Stock Analysis: 44.97% Potential Upside Captures Investor Attention

Investors with an eye on the healthcare sector may find Establishment Labs Holdings Inc (NASDAQ: ESTA) an intriguing option, especially given its impressive potential upside of..

Harrow, Inc. (HROW) Stock Analysis: Analyst Ratings Signal a Promising 51.12% Upside for Investors

Harrow, Inc. (HROW), a pivotal player in the healthcare sector, is gaining significant attention from investors due to its strong potential for growth. The company, headquartered..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating a 30% Potential Upside in HealthTech

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling opportunity for investors seeking exposure in the health information services sector, known for its innovative approach to healthcare..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Promising 153% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is catching the eye of investors with its ambitious approach to tackling serious immunological diseases. With a..

agilon health, inc. (AGL) Stock Analysis: Exploring the 23% Potential Upside

agilon health, inc. (NYSE: AGL) presents an intriguing proposition for investors focused on the healthcare sector, particularly given its role in transforming senior care. The company..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unpacking the Healthcare Giant’s Growth Potential and Market Position

Bausch Health Companies Inc. (NYSE: BHC), a prominent name in the healthcare sector, continues to be a focal point for investors keen on specialty and generic..

Investor Outlook: Travere Therapeutics, Inc. (TVTX) and Its 65% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) is garnering significant attention among investors, primarily due to its considerable potential upside. With a target price range that suggests a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Healthcare Investment with Modest Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within medical care facilities, is drawing attention from investors due to its..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 69.75% Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to immunotherapy. Headquartered in Abingdon,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring the 140% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company with a focus on developing therapeutic antibodies for severe inflammatory and autoimmune diseases, presents a compelling case for..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals a Compelling 135% Upside Potential

Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, not just for its innovative vaccine technologies but also for its intriguing investment potential. With..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 229% Potential Upside Awaits Investors

Investors monitoring the healthcare sector should take a closer look at Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical firm specializing in innovative cancer treatments. With..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth in Medical Devices with a 15.3% Revenue Surge

Artivion, Inc. (NASDAQ: AORT) stands out in the competitive healthcare landscape, particularly within the medical devices industry. With a market capitalization of $2.05 billion, this U.S.-based..

Vericel Corporation (VCEL): Investor Outlook Reveals 62% Potential Upside

Vericel Corporation (VCEL), a dynamic player in the biotechnology sector, presents a compelling case for investors with a notable potential upside of 62.18%. This commercial-stage biopharmaceutical..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 13% Upside Potential in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.67 billion, this..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 23.63% Potential Upside in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY), a notable player in the healthcare sector, specializes in fertility and family-building benefits solutions across the United States. With a market capitalization..

Supernus Pharmaceuticals, Inc. (SUPN) Investor Outlook: Balancing Promising CNS Pipeline with Recent Revenue Challenges

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the biopharmaceutical sector, is making strides in the treatment of central nervous system (CNS) diseases. With a robust..

SS Innovations International (SSII) Stock Analysis: Unpacking the 121.8% Revenue Growth in the Healthcare Sector

SS Innovations International Inc. (SSII), a trailblazer in the medical devices industry, has garnered attention with its impressive 121.8% revenue growth. Operating from its headquarters in..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring Its 161% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. The Singapore-based company, with a market..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a 43% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is capturing the attention of investors with its robust 43.28% potential upside, as evidenced by the average target price of $38.56..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds